Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Regenerative medical devices company Tissue Regenix said it had received a further $417k loan under the US government-backed Covid-19 business support scheme.
The funding was in addition to the receipt of a US government-backed loan of $629k announced on 15 April.
At 8:44am: (LON:TRX) Tissue Regenix Group PLC share price was +0.05p at 0.78p